Platinum-based chemotherapy (cisplatin or carboplatin) + pemetrexed or gemcitabine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Platinum-based chemotherapy (cisplatin or carboplatin) + pemetrexed or gemcitabine, covering 2021-02-18 to 2021-02-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110] [Phase 3]